ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

Investing Advice

HSBC's Very Embarrassing Bad Day(s)

Feb 23 2015 @ 10:51
You just know it’s going to be a bad day when it’s time to report a 17% decline in pretax profit for any period. This morning, HSBC Holdings (LSE:HSBA), Europe’s largest bank, reported a 17% decline for the entire 12 months ending 31 December. The company’s share price followed suit post-announcement, falling more than 5.1% […]
 

Information Overload: What You Really Need To Know To Trade Better

Feb 23 2015 @ 09:02
It has to be said: The antics of your mind throw many a spanner into your trading works.  There is no other way of putting it, you are the unwitting victim of your mind rather than being the master of it. This simple fact, which I also discussed in my last article:” Why Fundamentals Don’t […]
 

Daily analysis of major pairs for February 23, 2015

Feb 22 2015 @ 17:18
The USD/CHF moved upwards by 200 pips last week, topping at the resistance level of 0.9500. That resistance level was slashed upwards, but the price could not stay above it, for the price dived by 130 pips, closing below the resistance level at 0.9400. Another close below the support level at 0.9300 is possible this […]
 

Weekly Trading Forecasts on Major Pairs (February 23 - 27, 2015)

Feb 21 2015 @ 03:34
Here’s the market outlook for the week: EURUSD Dominant bias: Neutral This market is not currently favorable for swing trading, except intraday trading or scalping. This is because the market has not moved protractedly in a vivid direction for weeks. There is a support line at 1.1300 and a resistance line at 1.1450, and a […]
 

How Long Is ARM's Reach?

Feb 19 2015 @ 16:38
It has been one week since I used this space to discuss ARM Holdings (LSE:ARM) following its earnings report for 2014. In the interim, ARM’s share price has gained an additional 12 points. It is up 104 points (10%) since 01 January, closing today at 1,099.00. Every time I research ARM, I get the same […]
 

When a Good Strategy Is Losing Money – Part 1

Feb 18 2015 @ 18:28
“But in the market any price is always history. It’s the price of the last transaction, holding no guarantee for even the nearest future.” – Dirk Vandycke What do you do when a good trading system, whose historical results have been satisfactory, gets into a losing streak? Good strategies lose now and then, and then […]
 

Wood Group Says It Is Well-Positioned

Feb 17 2015 @ 15:03
Wood Group’s (LSE:WG.) share price gained 4.76% today on the London Exchange, closing at 660.00, up 30.00 points from yesterday’s close of 630.00. Today’s increase continues to build on a pattern that started on 14 January when the stock began recovering after hitting a 52-week low of 527.00. More than 2.5 million shares traded hands […]
 

Annual Trading Forecast on Microsoft (2015)

Feb 17 2015 @ 02:32
Microsoft shares (NASDAQ: MSFT) gapped downwards in January this year and since then, they have been making a slow attempt to recover. The outlook this month has been bullish so far. In the chart, the price has been challenging the upper Trendline and a break above it could make the price trend further north until […]
 

Annual Trading Forecast on Lloyds (2015)

Feb 17 2015 @ 02:22
Lloyds stock (LSE:LLOY) is not an attractive market at the moment. The choppy and volatile price is a pain to the speculator, except one waits for the price to start moving in a determined manner. The high volatility and choppy conditions happened last year and they are also happening this year, though the price is […]
 

AstraZeneca Has Investors Hyperventilating

Feb 16 2015 @ 14:47
The share price of FTSE 100 member, AstraZenca, plunged 82.50 points, a decline of 1.81%, to 4,468.50 today, following announcement of an adverse ruling by the U.S. District Court of New Jersey. The court ruled, in a continuation of a case that has been on the its docket since 2013, that AstraZeneca’s patent number 6,598,603 is […]
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com